A Phase 1, Open-Label, Age-Descending, Dose-Finding Study and A Phase 2/3, Placebo-Controlled, Randomized, Double-Blind Study To Evaluate the Safety, Tolerability and Immunogenicity of Respiratory Synctial Virus Perfusion F Subunit Vaccine - RSVpreF